NSE filing, NSE: VGUARD. Summary written from the filing by ALFA Finder's alert engine.
V-Guard Industries Ltd: key numbers
- Share price
- ₹265.90
- Market cap
- ₹11,618 Cr
- Revenue (annual)
- ₹5,966 Cr
- Net profit (annual)
- ₹308.3 Cr
- P/E (TTM)
- 31.9×Sector 41.7×
- Promoter holding
- 53.21%-0.01% QoQ
- FII holding
- 13.02%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from V-Guard Industries Ltd
All →V-Guard Industries Other Announcement
V-Guard Industries Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with regulatory disclosure requirements.
V-Guard Industries Board Meeting Date
V-Guard Industries scheduled its Board meeting for 29 Oct 2026 to approve Q1 and H1 FY27 unaudited results. No financial figures or transaction details are disclosed in this advance notice.
V-Guard Industries Promoter Selling: ₹17.14 Cr
Promoter and Promoter Group of V-Guard Industries Ltd sold 569,302 shares in the open market for an aggregate consideration of Rs. 17.14 Crore.
- Value
- ₹17.14 Cr
- Promoter stake change
- -0.14%
V-Guard Industries Management Change
V-Guard Industries announced Ms. Radha Unni's retirement as Independent Director and Chairperson. Managing Director Mr. Mithun K Chittilappilly will assume the position of Board Chairperson.
V-Guard Industries Other Announcement
Deepak Augustine, an employee of V-Guard Industries, sold 3,000 equity shares worth Rs. 10.41 lakh in a market sale transaction.
- Value
- ₹0.10 Cr
V-Guard Industries Capital Structure Change
ICICI Prudential Mutual Fund reduced its stake in V-Guard Industries Ltd by 2.11% through open market sales. The Fund's holding decreased from 7.04% to 4.93%.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date